11.4700最高价10.5350最低价61.65万股成交量10.9100今开10.5000昨收676.63万成交额4.39%换手率亏损市盈率(静)2000.14万总股本21.660052周最高1.10市净率1.54亿流通值6.500052周最低--股息TTM1403.13万流通股128.4400历史最高--股息率TTM8.91%振幅6.5000历史最低10.9750平均价1股每手 ...
Cybin Inc 是一家生物制药公司,致力于为患者创造安全有效的治疗方法,以解决多种心理健康问题。 该公司专注于推进基于迷幻剂的疗法、输送机制、新型化合物和方案,作为各种精神和神经系统疾病的潜在治疗方法。 公司介绍 公司代码CYBN 公司名称Cybin 上市日期2021/08/05 成立日期2016 CEOMr. Douglas Drysdale 所属市场美...
Our Team Cboe CA:CYBN$ CAD%view stock» NYSE:CYBN$ USD%view stock» In the Press
Our Team NEO:CYBN$0.43 CAD00%view stock» NYSE:CYBN$0.311 USD-0.002-0.639%view stock» In the Press
Stock Screener Stocks by Quant Top Stocks Top Quant Dividend Stocks High Dividend Yield Stocks Top Dividend Stocks ETFs & Funds ETF Screener ETF Analysis ETF Guide Mutual Funds Closed End Funds Editors' Picks Dividends Dividend Stock News REITs Dividend Ideas Dividend Strategy Dividend Quick Picks Edi...
Investor Alert Options * News Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Events & Presentations Unsubscribe REQUEST A MEETING WITH MANAGEMENT > Our Work Development Pipeline Partnerships Embark Investors Overview News Events & Presentations Stock Info Financials Governance Quic...
Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. ...
加拿大投资银行集团:维持Cybin(CYBN.US)评级,由买入调整至买入评级, 目标价由86.00美元调整至86.00美元。 Cybin(CYBN.US)公司简介:Cybin Inc 是一家生物制药公司,致力于为患者创造安全有效的治疗方法,以解决多种心理健康问题。 该公司专注于推进基于迷幻剂的疗法、输送机制、新型化合物和方案,作为各种精神和神经系统...
October 28, 2024 · 3 min read · Tristan Manalac Business Meeting on the Mesa to Highlight Cell and Gene Therapy Opportunities, Challenges October 3, 2024 · 7 min read · Greg Slabodkin Bladder cancer AstraZeneca’s Perioperative Imfinzi...
Cybin Inc. today announced positive Phase 2 topline safety and efficacy data for CYB003, its proprietary deuterated psilocybin analog, being developed for the treatment of major depressive disorder (“MDD”).